Preparation method and application of anti-human leukemia inhibitory factor monoclonal antibody
A monoclonal antibody and inhibitory factor technology, applied in biochemical equipment and methods, anti-animal/human immunoglobulin, antibodies, etc., to achieve enhanced therapeutic effect, improved therapeutic effect, and strong affinity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0052] The preparation method of recombinant human leukemia inhibitory factor is:
[0053] S1: Mix Tris-HCL, NaCl, and EDTA, and the concentrations of the three in the mixture reach 20mM, 60mM, and 1mM respectively, then add Triton X-100 to make the concentration reach 0.5%, and obtain a lysate for later use.
[0054] S2: Inoculate Escherichia coli containing the expression vector of human leukemia inhibitory factor into LB medium, culture overnight at 37°C and 200 rpm, then inoculate in freshly prepared LB medium at a volume ratio of 1:50, and incubate at 37°C 200 rpm shaking culture until the bacterial OD600nm detection result reaches 0.6, add IPTG with a final concentration of 0.5mM to induce, then reduce the temperature of the bacterial culture solution to 16°C, and change the bacterial culture temperature to 16°C at the same time, continue for 200 Harvest the bacteria after shaking and culturing for 20 hours; after weighing the harvested bacteria, add the lysate according...
Embodiment 2
[0059] The immunization method of experimental animals is as follows:
[0060] Apply 80 μg of recombinant human leukemia inhibitory factor protein mixed with an equal volume of complete Freund's adjuvant to immunize 8-week-old female BALB / c mice. After the first immunization, boost immunization every 2 weeks. After a total of 3 immunizations, apply ELISA The method detects that the titer of mouse serum reaches 1:10 5 At that time, the mouse with the highest serum titer was selected, and the mice were given a booster immunization once. After 3 days, the mice were sacrificed, and the spleen was aseptically removed and ground on a plate to make a spleen single cell suspension for later use.
Embodiment 3
[0062] The preparation method of hybridoma cells is as follows:
[0063] Mouse SP2 / 0 myeloma cells were revived while immunizing mice. For cell fusion, take the SP2 / 0 myeloma cells in the logarithmic growth phase, wash them twice with incomplete RPMI-1640 medium, resuspend and induce fusion with the above-mentioned spleen single cell suspension with 50% PEG4000. Selective culture was carried out in RPMI1640 medium for 1 week, the supernatant was drawn, and the antibody secretion was detected by indirect ELISA method. 2 μg / mL antigen was coated with 100 μL / well of the volume (human leukemia inhibitory factor protein) on a 96-well plate, and the washing solution After washing three times, add 150 μL / well blocking solution to block at room temperature for 2 hours, and pat dry after washing. Add the supernatant of the cells to be tested, dilute to 8 concentrations according to a 2-fold gradient, incubate at 37°C for 1 hour, wash the plate and pat dry, take horseradish peroxidase-...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com